Krystal Biotech, Inc. (KRYS)

Krystal Biotech Stock Forecast

Stock Price Forecast

According to 8 professional analysts, the 12-month price target for Krystal Biotech stock ranges from a low of $155 to a high of $245. The average analyst price target of $211.13 forecasts a 54.18% increase in the stock price over the next year.

Price Target: $211.13 (+54.18%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$155	$211.13	$219	$245
Change	+13.19%	+54.18%	+59.92%	+78.91%

Analyst Ratings

The average analyst rating for Krystal Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	4	3	4	4	5
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	6	7	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Hold Maintains $215 → $155	Hold	Maintains	$215 → $155	+13.19%	May 16, 2025
Debjit Chattopadhyay Guggenheim	Guggenheim	Strong Buy Maintains $195 → $189	Strong Buy	Maintains	$195 → $189	+38.02%	May 7, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $219	Strong Buy	Maintains	$219	+59.92%	May 7, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $240	Strong Buy	Reiterates	$240	+75.26%	May 6, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $221 → $240	Strong Buy	Maintains	$221 → $240	+75.26%	Apr 29, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

418.49M

Increased by 44.05%

from 290.52M

Revenue Next Year

611.61M

Increased by 46.15%

from 418.49M

EPS This Year

6.13

Increased by 104.31%

from 3.00

EPS Next Year

9.69

Increased by 58.16%

from 6.13

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	50.70M	290.52M	418.49M	611.61M	849.87M
Revenue Growth	-	-	-	-	473.02%	44.05%	46.15%	38.96%
EPS	-1.71	-3.13	-5.49	0.39	3.00	6.13	9.69	13.81
EPS Growth	-	-	-	-	669.23%	104.31%	58.16%	42.42%
Forward PE	-	-	-	-	-	22.34	14.13	9.92
No. Analysts	-	-	-	-	-	13	13	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	470.4M	803.8M	1.1B
Avg	418.5M	611.6M	849.9M
Low	361.5M	412.4M	692.4M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	61.9%	92.1%	87.4%
Avg	44.1%	46.1%	39.0%
Low	24.4%	-1.5%	13.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	8.39	14.88	26.20
Avg	6.13	9.69	13.81
Low	4.48	6.17	8.39

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	179.7%	142.7%	170.2%
Avg	104.3%	58.2%	42.4%
Low	49.3%	0.7%	-13.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.